Marc Johnson Profile picture
Aug 17, 2024 15 tweets 5 min read Read on X
I'm giving the variant update at the SAVE meeting on Monday so I thought I'd put out a preview for comment.

We are now at our 4th 'high water' mark since the Omicron wave based on wastewater surveillance.

1/ Image
I thought I would give an abbreviated summary of the last year in variants.

A little over a year ago BA.2.86 started circulating, a lineage that was almost certainly derived from a persistent infection.
2/ Image
BA.2.86 was pretty fit, but it was still sensitive to a lot of Class 1 antibodies.

However, it quickly picked up S:L455S (making it JN.1), which evaded these antibodies, and it was off to the races.
3/ Image
JN.1 played around with a lot of mutations, but its favorite was F456L, a change that it independently picked up at least 20 times.
4/ Image
We then started seeing lineages that combined 456L with the old favorite R346T, which was the same change that BA.4/5 picked up during the summer 2 years ago.

This happened lots of times, but the best know was probably KP.2.
5/ Image
But those lineages got some competition when another 456L lineage picked up R493E (KP.3).

For whatever reason this really only happened once. I'm not sure why. It was a C->G mutation, which is rare.

KP.3 seemed to be fitter than the 456L/346T gang.
6/ Image
I always expected KP.3 to pick up R346T, but there hasn't appeared to be much selective pressure for that to happen. There's probably some redundancy in 346T/493E advantages.

7/
Then the 346T/456L group found a neat trick. They deleted position S31, which gave them the leg up again.

8/ Image
But of course, KP.3 figured out that it could do that too.
The S31 deletion has occurred lots of times now, but the fittest among them seems to be KP.3.1.1.
9/ Image
So what does the S31 deletion do. It's been reported to both increase fitness (higher infectivity in pseudotype assays), and antibody evasion.

The deletion introduces a glycosylation site, but it also restores the insertions/deletion balance in that part of Spike.
10/ Image
RaTG-13 had a glycosylation site at this position too, and I've seen it introduced in lots of cryptic lineages.

However, I never saw the 31 deletion until the JN.1 insertion occurred. Probably because of the insertion/deletion balance thing.

11/ Image
If I were smart I would put a 3D structure here showing why they insertion/deletion balance is important, but I'm not that smart (and it's just a theory).

12/
So what are we watching now?

There is a chimera-of-chimeras in China called XDV.1 that is doing pretty well there, but not really anywhere else.

Its spike is derived from JN.1, but it doesn't have any of the 'advanced' changes.

It does have the XBB Orf9b:I5T though.

13/ Image
Finally there is the new chimera that just got designated, XEC. This one just appeared in June and has fared pretty well. I don't think it could keep up with KP.3.1.1 currently, but if it picks up a few more changes it might.

14/ Image
Overall it's an odd time. It's pretty clear that KP.3.1.1 (and equivalent) is going to have a sweep the world the way that JN.1 did, but I'm not sure what happens after that.

We'll be watching.
15/15

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Marc Johnson

Marc Johnson Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @SolidEvidence

Mar 1
So what's happening with medical research in the US? This is the cumulative award count from the NIH for the year.

Doesn't look so good.

But it gets worse.
1/ Image
Before grants are awarded, they have to be evaluated in meetings called study sections.

Before a study section can meet, it has to be listed in the federal registry for at least 15 days.

These are the new study section meetings listed in the federal registry this year.
2/ Image
Meetings can't even be scheduled, none of the committed funds are going out.

About 300,000 scientists are wondering if they are going to keep their jobs, and the most vulnerable are the students and postdocs.
3/
Read 4 tweets
Feb 28
There something new on the SARS-CoV-2 landscape, and I’m not sure what it is.
1/ Image
S:S31F and S:K182N are on the rise.

The two aren’t on the same sequencing strand, but I confirmed that they are generally appearing together in the same samples.

2/
The samples are from across the country (CA, WY, LA, CT, PA, WI, etc) and more than one sequencing group, so it’s probably not a sequencing error.

3/
Read 5 tweets
Feb 11
Brief update on the new cryptic lineage we found from Petersburg City, Virginia.

We went back and screened all of the samples from that sewershed since the beginning of 2024 and learned a few things about it.
1/ Image
First, I think I was wrong about the lineage being JN.1 derived. I thought it was JN.1 because it had 22926C (455S), but it looks like it only acquired that recently.

In samples as recent as December the lineage lacked 455S and 456L.
2/ Image
That would mean the lineage is BA.2.86-derived, which suggests it was acquired probably early 2024.

Caveat, as @LongDesertTrain points out, persist infections hate 455S. It’s possible that the lineage was JN.1, but reverted at 455, but then gained 2 nt creating 455A.
3/ Image
Read 8 tweets
Jan 31
Wastewater variant update. This is the composite data from over 1,000 US samples collected over the last 6 weeks.
1/ Image
You have to extrapolate a little bit because several changes are shared by multiple lineages.

It appears that the new lineage I mentioned last week (MC.10.1 + 445P) is around 4% and is the fastest growing of the lot. It now has a PANGO designation - PA.1
2/
LP.8 is still expanding is is probably about 12% now. Since it is a KP.3.1.1 derivative, KP.3.1.1* might become dominant again.

LF.7 seems to be holding on too at about 4%.
3/
Read 7 tweets
Jan 26
Here's the latest composite US wastewater data.

It's a little bit confusing this week.

1/ Image
Clearly LP.8 is still the main lineage gaining traction. All of its changes are moving in the same direction (up).

LF.7 is much lower, but looking a little bit more alive than last week.
2/ Image
445P is mixed. It is decreasing, but we know that the signal is a mix of LB.1.3.1 and a new lineage which is MC.10.1+445P (which also has A435S).

445P is decreasing, but much of that is likely the drop in LB.1.3.1 when you compare to 183H.

3/
Read 6 tweets
Jan 24
What fraction of patient sequences are derived from persistent SARS-CoV-2 infections? (volume 3)

This is something that we can actually calculate.
1/
The key is the mutation Orf1a:K1795Q, which frequently appears in persistent infections (and even more often in cryptic lineages).

2/
Each time I make this calculation, I check 2 empirical numbers.

1. What fraction of sequences with Orf1a:K1795Q are from persistent infections

2. What fraction of persistent infections acquire Orf1a:K1795Q

3/
Read 17 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(